Furthermore, elucidating cytokine signatures associated with tumor immune modulation may deepen our understanding of NSCLC immunobiology—particularly in relation to immune checkpoint pathways such as PD-L1 and CTLA-4—and contribute to the development of integrated diagnostic and therapeutic strategies. The gene discussed is CD274; the disease is non-small cell lung carcinoma.